Greedy Insider · Filing
PMN · Buy · Cashman Neil
Cashman Neil (Chief Scientific Officer) bought 10,000 shares of ProMIS Neurosciences Inc. (PMN) at $3.86, about $39K, on Nov 2, 2026, filed with the SEC on Nov 3, 2026.
Greediness Score 54 · Mixed · high confidence. Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0001374339-26-000009